Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA plus Climen versus DHEA alone for diminished ovarian reserve in IVF patients
ChiCTR-TRC-14005030Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Aug 2014
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dehydroepiandrosterone and estradiol valerate + cyproterone acetate in Diminished Ovarian Reserve (DOR) and infertility (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Anti-Mullerian hormone, Follicle-stimulating hormone and 1 more. Started Aug 2014; status: recruiting.
02
Drugs
dehydroepiandrosteroneestradiol valerate + cyproterone acetate
03
Conditions
Diminished Ovarian Reserve (DOR)infertility
Beyond the preview
Go deeper on ChiCTR-TRC-14005030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005030.